H36.822
Proliferative sickle-cell retinopathy, left eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Proliferative sickle-cell retinopathy is a serious eye condition that can affect individuals with sickle cell disease, primarily involving abnormal blood vessel growth in the retina. When it occurs in the left eye, it can lead to vision problems if not diagnosed and managed promptly. This condition results from changes in the blood vessels of the retina, the light-sensitive tissue at the back of the eye, caused by the sickling of red blood cells.
Causes & Symptoms
Clinical Causes: Sickle cell disease leading to abnormal, sickled red blood cells Blockage of small blood vessels in the retina due to sickled cells, causing ischemia (lack of oxygen) Compensatory growth of new, fragile blood vessels as a response to retinal ischemia Genetic predisposition, particularly in individuals with sickle cell hemoglobinopathies
Key Symptoms: Gradual loss of vision in the affected eye Seeing floaters or flashes of light Blind spots in the visual field Blurred or distorted vision No noticeable symptoms in early stages, with progression leading to more obvious vision changes
Diagnostic & Treatment
Diagnosis Path: Fluorescein angiography, to assess abnormal blood vessels and areas of ischemia Optical coherence tomography (OCT), to evaluate retinal layers and detect edema or scarring Medical history review emphasizing sickle cell disease history Blood tests to confirm sickle cell status and hemoglobin types
Treatment Protocols: Laser photocoagulation therapy to seal off abnormal blood vessels and prevent further bleeding or scarring Anti-vascular endothelial growth factor (anti-VEGF) injections to reduce abnormal vessel growth Management of sickle cell disease to minimize sickling episodes and vascular damage Regular monitoring to detect disease progression early Surgical interventions, such as vitrectomy, in advanced cases with retinal detachment or hemorrhage
Clinical Advice & FAQs
Billing Guidance
Is H36.822 a billable ICD-10 code?
Yes, H36.822 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.822?
Clinical documentation must specify the nature of Proliferative sickle-cell retinopathy, left eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference